Combined Chelation Treatment With Deferiprone and Deferoxamine in Thalassemia Major

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT00103753

Recruitment Status : Unknown

Verified February 2005 by Royal Brompton & Harefield NHS Foundation Trust.
Recruitment status was: Active, not recruiting

First Posted : February 15, 2005

Last Update Posted : June 24, 2005

Sponsor:

Collaborators:

CORDA, The Heart Charity

The Cooley's Anemia Foundation,

Apotex Inc.

The UK Thalassemia Society

Information provided by:

Royal Brompton & Harefield NHS Foundation Trust

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Unknown
Primary Completion Date :	No date given
Study Completion Date :	June 2005

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Tanner MA, Galanello R, Dessi C, Smith GC, Westwood MA, Agus A, Pibiri M, Nair SV, Walker JM, Pennell DJ. Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction. J Cardiovasc Magn Reson. 2008 Feb 25;10:12. doi: 10.1186/1532-429X-10-12.

To Top